glp-1 obesity drug market news today GLP-1 Market Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 Market Overview: GLP-1 Agonists and
Description
moreover, similar GLP-1RA effect sizes suggest a lack of sufficient power rather than a lack of effect
With obesity linked to hypertension, dyslipidemia, sleep apnea, cardiovascular disease, fatty liver disease, and kidney complications, GLP-1 drugs have become platform therapies rather than single-indication products
Novel advances in monitoring and therapeutic approaches in idiopathic intracranial hypertension
doi: 10.1016/j.jss.2025.05.016
What is the risk of getting gastroparesis with Ozempic
Diabetes, oncology, respiratory diseases, and neurology remain dominant segments
